A new perspective on gut immunity is highlighting the powerful role of RNA modifications in shaping how the body maintains balance in the digestive system. At the center of this emerging view are intestinal macrophages, highly adaptable immune cells that act as guardians of the gut, protecting against harmful invaders while preserving harmony with beneficial microbes.
These cells operate in one of the body’s most complex environments, where they must continuously interpret signals from microbiota, surrounding tissues, and dietary inputs. Their ability to respond appropriately depends on remarkable cellular plasticity, allowing them to shift between pro-inflammatory and anti-inflammatory states as conditions change. This flexibility is now understood to be tightly controlled by epitranscriptomic regulation, a process that modifies RNA to influence how genes are expressed.

Key to this regulation are chemical changes to RNA, including m6A, m1A, and m5C modifications. These molecular adjustments act as precise control points, determining how macrophages develop, function, and communicate. By influencing processes such as cytokine production, metabolic activity, and tissue repair, RNA modifications enable immune cells to rapidly adapt to their surroundings.

The significance of these mechanisms becomes especially clear in the context of disease. When RNA modification pathways are disrupted, macrophages can become imbalanced, leading to excessive inflammation or impaired healing. Such dysfunction is closely linked to conditions like inflammatory bowel disease and colorectal cancer, where immune responses fail to resolve properly and instead contribute to ongoing tissue damage.

The gut microenvironment plays a crucial role in shaping these outcomes. Signals from the microbiome, including metabolites and microbial byproducts, directly influence the enzymes responsible for adding or removing RNA modifications. This creates a dynamic feedback system in which environmental factors and immune responses are tightly interconnected.

Equally important are the interactions between macrophages and neighboring cells. Close communication with intestinal epithelial cells, stromal cells, and the enteric nervous system ensures coordinated responses that maintain barrier integrity and support regeneration. RNA modifications help regulate these interactions, fine-tuning immune activity to match the needs of the tissue.

This evolving understanding opens the door to innovative therapeutic strategies. By targeting RNA modification pathways, it may be possible to reprogram immune responses, reduce harmful inflammation, and restore balance in the gut. Such approaches represent a promising direction for treating complex intestinal disorders.

As knowledge in this area continues to expand, RNA modifications are emerging as a central mechanism linking immunity, inflammation, and the gut environment, offering new possibilities for precision medicine in digestive health.

# # # # # #
Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis is placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.
Scopus CiteScore: 8.4 |Impact Factor: 9.4
# # # # # #
More information: https://www.keaipublishing.com/en/journals/genes-and-diseases/
Editorial Board: https://www.keaipublishing.com/en/journals/genes-and-diseases/editorial-board/
All issues and articles in press are available online in ScienceDirect (https://www.sciencedirect.com/journal/genes-and-diseases).
Submissions to Genes & Diseases may be made using Editorial Manager (https://www.editorialmanager.com/gendis/default.aspx).
Print ISSN: 2352-4820
eISSN: 2352-3042
CN: 50-1221/R
Contact Us: editor@genesndiseases.cn
X (formerly twitter): @GenesNDiseases (https://x.com/GenesNDiseases)
# # # # # #
Reference
Manqiqige Su, Jiyuan Fan, Hua-Bing Li, RNA modifications in intestinal macrophages: Implications for gut immunity and inflammation, Genes & Diseases, Volume 13, Issue 2, 2026, 101881, https://doi.org/10.1016/j.gendis.2025.101881

Funding
National Natural Science Foundation of China 82341017
National Natural Science Foundation of China 82030042
National Natural Science Foundation of China 82325024
National Natural Science Foundation of China 82350112
National Natural Science Foundation of China 82461160323
National Natural Science Foundation of China 82441048
National Key R&D Program of China 2025YFC3410100
National Key R&D Program of China 2021YFA1100800
Shanghai Municipal Health Commission of China 2022XD047
Shanghai Municipal Health Commission of China 2022JC0